Abstract
Targeted Therapy; From Advanced Melanoma to the Adjuvant Setting
Highlights
Targeted therapy has revolutionized treatment for advanced melanoma
Clinical trials have demonstrated unprecedented survival benefits in advanced melanoma patients treated with Vemurafenib [1, 2]
There is a high demand for new and effective adjuvant treatments to mitigate the risk of recurrence, and there are a number of adjuvant therapies under investigation for stage IIB-C and stage III patients
Summary
Targeted therapy has revolutionized treatment for advanced melanoma. Clinical trials have demonstrated unprecedented survival benefits in advanced melanoma patients treated with Vemurafenib [1, 2]. There is a high demand for new and effective adjuvant treatments to mitigate the risk of recurrence, and there are a number of adjuvant therapies under investigation for stage IIB-C and stage III patients.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
